Quick Takeaways
- John Hohneker has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $331,345.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of John Hohneker
- Location
- Cambridge, MA
- Summary
- The estimated net worth of John Hohneker is at least $331,345 dollars as of 20 Jun 2025. John Hohneker is the Director of HUMANIGEN, INC and owns shares of HUMANIGEN, INC stock worth about $286.3K. John Hohneker is the Director of CURIS INC and owns shares of CURIS INC (CRIS) stock worth about $45.1K.
- Signature
- By: /s/ James Kastenmayer, Attorney-in-Fact for John Hohneker
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow John Hohneker and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: HUMANIGEN, INC ($286,273).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of John Hohneker
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| HGEN | HUMANIGEN, INC | Director | $286,273 | 27 Jul 2022 | ||
| CRIS | CURIS INC | Director | $45,072 | 20 May 2025 | ||
| ARAV | Aravive, Inc. | Director | 23 Sep 2022 | |||
| AVBP | ArriVent BioPharma, Inc. | Director | 18 Jun 2025 | |||
| CARM | Carisma Therapeutics Inc. | Director | 26 Jun 2024 | |||
| EVLO | Evelo Biosciences, Inc. | Director | 08 Jun 2023 |
Insider Transactions Reported by John Hohneker:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.